131 related articles for article (PubMed ID: 7038504)
1. Reversal of natural killer defect in a patient with Chédiak-Higashi syndrome after bone-marrow transplantation.
Virelizier JL; Lagrue A; Durandy A; Arenzana F; Oury C; Griscelli C; Reinert P
N Engl J Med; 1982 Apr; 306(17):1055-6. PubMed ID: 7038504
[No Abstract] [Full Text] [Related]
2. Natural killer cell activity in a patient with Chédiak-Higashi syndrome submitted to bone marrow transplantation.
Diamond HR; Souza MH; Silva ML; Tabak DG; Ferman S; M-Silva VM; de La Rocque L; Rumjanek VM
Pediatr Hematol Oncol; 1995; 12(4):399-402. PubMed ID: 7577393
[No Abstract] [Full Text] [Related]
3. Bone marrow transplantation in a patient with Chédiak-Higashi Syndrome.
Griscelli C; Virelizier JL
Birth Defects Orig Artic Ser; 1983; 19(3):333-4. PubMed ID: 6360244
[No Abstract] [Full Text] [Related]
4. Chediak-Higashi syndrome: reversal of increased susceptibility to infection by bone marrow transplantation.
Kazmierowski JA; Elin RJ; Reynolds HY; Durbin WA; Wolff SM
Blood; 1976 Apr; 47(4):555-9. PubMed ID: 769863
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases.
Haddad E; Le Deist F; Blanche S; Benkerrou M; Rohrlich P; Vilmer E; Griscelli C; Fischer A
Blood; 1995 Jun; 85(11):3328-33. PubMed ID: 7756666
[TBL] [Abstract][Full Text] [Related]
6. Chediak-Higashi syndrome natural killer cells: a protein kinase C defective activation/regulation defect?
Merino F; Esparza B; Sabino E
Eur J Pediatr; 1996 Mar; 155(3):254. PubMed ID: 8929738
[No Abstract] [Full Text] [Related]
7. Chédiak-Higashi syndrome: hematopoietic chimerism corrects genetic defect.
Trigg ME; Schugar R
Bone Marrow Transplant; 2001 Jun; 27(11):1211-3. PubMed ID: 11551033
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of inducible suppressor cell activity in the Chediak-Higashi syndrome.
Nair MP; Gray RH; Boxer LA; Schwartz SA
Am J Hematol; 1987 Sep; 26(1):55-66. PubMed ID: 2443005
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a murine model (beige) for a natural killer cell immunodeficiency in the Chediak-Higashi syndrome of man.
Roder JC
Prog Clin Biol Res; 1982; 94():315-25. PubMed ID: 7122620
[No Abstract] [Full Text] [Related]
10. [The accelerated phase of Chediak-Higashi syndrome].
Bejaoui M; Veber F; Girault D; Gaud C; Blanche S; Griscelli C; Fischer A
Arch Fr Pediatr; 1989 Dec; 46(10):733-6. PubMed ID: 2697195
[TBL] [Abstract][Full Text] [Related]
11. In vivo Epstein Barr virus-induced augmentation of natural killer cell activity in the Chédiak-Higashi syndrome.
Katz P; Zaytoun AM; Lee JH; Fauci AS
J Immunol; 1984 Feb; 132(2):571-3. PubMed ID: 6197464
[No Abstract] [Full Text] [Related]
12. T gamma cells in Chediak-Higashi syndrome.
van de Griend RJ; Astaldi A; de Bruin HG; Weening RS
N Engl J Med; 1982 Jun; 306(22):1368-9. PubMed ID: 6978462
[No Abstract] [Full Text] [Related]
13. [Chediak-Higashi disease: a new case treated by bone marrow allograft].
Demory JL; Senlecq-Tack S; Decoster A; Duhamel M; Spyckerelle C; Vittu G; Cousin J; Fischer A; Griscelli C
Ann Pediatr (Paris); 1989 Jun; 36(6):387-9. PubMed ID: 2667428
[TBL] [Abstract][Full Text] [Related]
14. Altered lectin-mediated cytotoxicity in Chédiak-Higashi syndrome patients.
Merino F; Rodríguez F; Biondo-Bracho M; Amesty C; Ramírez-Duque P
Clin Immunol Immunopathol; 1984 Nov; 33(2):139-43. PubMed ID: 6333304
[No Abstract] [Full Text] [Related]
15. [Chediak-Higashi syndrome in an adult female].
Utsunomiya A; Saito T; Hanada S; Tin E; Oshige T; Hashimoto S; Hamaguchi Y; Ueno T
Rinsho Ketsueki; 1988 Sep; 29(9):1422-6. PubMed ID: 3216514
[No Abstract] [Full Text] [Related]
16. Hyperpigmentation in Chediak-Higashi syndrome.
Al-Khenaizan S
J Am Acad Dermatol; 2003 Nov; 49(5 Suppl):S244-6. PubMed ID: 14576641
[TBL] [Abstract][Full Text] [Related]
17. Chediak-Higashi syndrome: clinical, hematologic, and immunologic improvement after splenectomy.
Harfi HA; Malik SA
Ann Allergy; 1992 Aug; 69(2):147-50. PubMed ID: 1510287
[TBL] [Abstract][Full Text] [Related]
18. Defects of immune interferon secretion and natural killer activity in patients with immunological disorders.
Virelizier JL; Lipinski M; Tursz T; Griscelli C
Lancet; 1979 Sep; 2(8144):696-7. PubMed ID: 90787
[No Abstract] [Full Text] [Related]
19. Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome.
Tardieu M; Lacroix C; Neven B; Bordigoni P; de Saint Basile G; Blanche S; Fischer A
Blood; 2005 Jul; 106(1):40-2. PubMed ID: 15790783
[TBL] [Abstract][Full Text] [Related]
20. Rapid ultrastructural detection of success or failure after bone marrow transplantation in the Chediak-Higashi syndrome.
White JG; Hess RA; Gahl WA; Introne W
Platelets; 2013; 24(1):71-4. PubMed ID: 22738378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
